secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001156039-26-000006
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q4 adj. EPS $3.33 on higher medical costs; FY2026 adj. EPS guide $25.50, down from $30.29
--------------------------------------------------------------------------------

- Q4 2025 GAAP diluted EPS $2.47; adjusted $3.33; operating revenue $49.3B (+10% YoY).
- Full year 2025 GAAP EPS $25.21; adjusted $30.29; operating revenue $197.6B (+13% YoY).
- Health Benefits segment Q4 adjusted operating loss of $0.2B; benefit expense ratio 93.5% (+110 bps YoY).
- FY2026 guidance: GAAP EPS at least $22.30; adjusted EPS at least $25.50; targeting 12% adjusted EPS growth in 2027.
- Returned $4.1B to shareholders in 2025; quarterly dividend raised to $1.72 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000006/0001156039-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000006/elv-20260128.htm
  HTML page:      https://secwatch.observer/filing/0001156039-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer